Peptidylarginine deiminase IV (PADI4) is not essential for cell-autonomous HSC maintenance and normal haematopoiesis (2021)

First Author: Young C

Attributed to: Therapeutic targeting of HIF prolyl hydroxylases in acute myeloid leukaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.04.13.439513

Publication URI: http://dx.doi.org/10.1101/2021.04.13.439513

Type: Preprint